Healthcare professionals
Always at the service of the medical community
At Ferrer we ensure that the medical community is reliably informed about the use and administration of our medications.
It is essential that healthcare professionals have in-depth knowledge of any new developments in the diagnosis and treatment of the therapeutic areas in which we operate so that they can later be transferred to their patients and, ultimately, benefit people's health.
We offer you our full potential
-
Therapeutic areas
We focus on pulmonary vascular and interstitial lung diseases, as well as rare neurological disorders. -
Diseases
We focus on low-prevalence diseases that have a profound impact on the lives of patients and caregivers. -
Pharmaceuticals
We develop treatments designed to improve quality of life in therapeutic areas where treatment options are limited. -
Pipeline
Our pipeline brings together molecules designed to address unmet medical needs in complex diseases. -
Clinical Trials
We conduct clinical trials to generate robust evidence in underserved diseases. -
Expanded Access Programs
We support early access programs that provide patients with urgent medical needs access to investigational therapies.
WE USE BUSINESS TO FIGHT FOR SOCIAL JUSTICE
Related news
-
Ferrer and Prilenia Announce Start of PRECISE-HD Confirmatory Clinical Trial of Pridopidine in Huntington's Disease
5 -
First participant in Europe in the Phase 3 clinical trial "PREVAiLS" with pridopidine, in ALS
5 -
IMPAHCT celebrates its eighth edition by reinforcing the comprehensive approach to rare lung diseases
5 -
Ferrer Spain promotes the foundations of a new value-based public procurement model
5 -
We completed the recruitment of 220 patients for PROSPER, the Phase II clinical trial in progressive supranuclear palsy
5
